UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Influence of resuspension volume on dry sampling devices taken for human papillomavirus testing: implications for self-sampling

BioTechniques, 2023-02, Vol.74 (2), p.77-84

2023

Volltextzugriff (PDF)

Direct bisulphite conversion of cervical samples for DNA methylation analysis

Epigenetics, 2022-10, Vol.17 (10), p.1173-1179

2022

Volltextzugriff (PDF)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

BMC cancer, 2020-05, Vol.20 (1), p.396-396, Article 396

2020

Volltextzugriff (PDF)

Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN)

Cancers, 2022-04, Vol.14 (7), p.1836

2022

Volltextzugriff (PDF)

Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings

PloS one, 2016-11, Vol.11 (11), p.e0165847-e0165847

2016

Volltextzugriff (PDF)

Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in Ghana

Tumour virus research, 2023-06, Vol.15, p.200261-200261, Article 200261

2023

Volltextzugriff (PDF)

YIP1 family member 4 (YIPF4) is a novel cellular binding partner of the papillomavirus E5 proteins

Scientific reports, 2015-08, Vol.5 (1), p.12523, Article 12523

2015

Volltextzugriff (PDF)

Host chemokine signature as a biomarker for the detection of pre-cancerous cervical lesions

Oncotarget, 2018-04, Vol.9 (26), p.18548-18558

2018

Volltextzugriff (PDF)

Increased cycling cell numbers and stem cell associated proteins as potential biomarkers for high grade human papillomavirus+ve pre-neoplastic cervical disease

PloS one, 2014-12, Vol.9 (12), p.e115379-e115379

2014

Volltextzugriff (PDF)

HPV infection and pre-term birth: a data-linkage study using Scottish Health Data

Wellcome open research, 2019, Vol.4, p.48-48

2019

Volltextzugriff (PDF)

Sensitivity of RT-PCR testing of upper respiratory tract samples for SARS-CoV-2 in hospitalised patients: a retrospective cohort study

Wellcome open research, 2020, Vol.5, p.254

2020

Volltextzugriff (PDF)

Characterisation of the vaginal microbiome in cervical intraepithelial neoplasia

The Lancet (British edition), 2016-02, Vol.387, p.S75-S75

2016

Volltextzugriff (PDF)

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

The Lancet infectious diseases, 2017-12, Vol.17 (12), p.1293-1302

2017

Volltextzugriff (PDF)

HPV testing in the context of post-treatment follow up (test of cure)

Journal of clinical virology, 2016-03, Vol.76, p.S56-S61

2016

Volltextzugriff (PDF)

Clinical performance of the novel full‐genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework

International journal of cancer, 2024-02, Vol.154 (3), p.538-547

2024

Volltextzugriff (PDF)

Agreement between L1 and E6/E7-based assays for detection of high-risk HPV in cervical, oropharyngeal and penile cancers

Journal of clinical pathology, 2023-07, Vol.76 (7), p.467

2023

Volltextzugriff (PDF)

The challenges of defining sample adequacy in an era of HPV based cervical screening

Journal of clinical virology, 2021-04, Vol.137, p.104756-104756, Article 104756

2021

Volltextzugriff (PDF)

The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis

Journal of clinical virology, 2023-07, Vol.164, p.105469-105469, Article 105469

2023

Volltextzugriff (PDF)

Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study

Journal of clinical virology, 2022-06, Vol.150-151, p.105165-105165, Article 105165

2022

Volltextzugriff (PDF)

Metaproteomic analysis from cervical biopsies and cytologies identifies proteinaceous biomarkers representing both human and microbial species

Talanta (Oxford), 2024-10, Vol.278, p.126460, Article 126460

2024

Volltextzugriff (PDF)

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework

Journal of clinical pathology, 2023-03, Vol.76 (3), p.172

2023

Volltextzugriff (PDF)

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework

Journal of medical virology, 2023-01, Vol.95 (1), p.e28417-n/a

2023

Volltextzugriff (PDF)

The potential of biobanked liquid based cytology samples for cervical cancer screening using Raman spectroscopy

Journal of biophotonics, 2019-07, Vol.12 (7), p.e201800377-n/a

2019

Volltextzugriff (PDF)

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years

Clinical infectious diseases, 2023-02, Vol.76 (3), p.e827-e834

2023

Volltextzugriff (PDF)

Validation of EUROArray HPV test using the VALGENT framework

Journal of clinical virology, 2018-11, Vol.108, p.38-42

2018

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(24)
Humans
(20)
Human Papillomavirus
(19)
Female
(18)
Cervical Cancer
(13)
Medical Screening
(11)
Papillomaviridae - Genetics
(11)
Papillomavirus Infections - Diagnosis
(9)
Virology
(9)
Hpv
(8)
Dna
(7)
Womens Health
(7)
Adult
(6)
Cancer
(6)
Cellular Biology
(6)
Cervix
(6)
Genotype
(6)
Human Papillomavirus Viruses
(6)
Laboratories
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Influence of resuspension volume on dry sampling devices taken for human papillomavirus testing: implications for self-sampling

Direct bisulphite conversion of cervical samples for DNA methylation analysis

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN)

Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings

Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in Ghana

YIP1 family member 4 (YIPF4) is a novel cellular binding partner of the papillomavirus E5 proteins

Host chemokine signature as a biomarker for the detection of pre-cancerous cervical lesions

Increased cycling cell numbers and stem cell associated proteins as potential biomarkers for high grade human papillomavirus+ve pre-neoplastic cervical disease

HPV infection and pre-term birth: a data-linkage study using Scottish Health Data

Sensitivity of RT-PCR testing of upper respiratory tract samples for SARS-CoV-2 in hospitalised patients: a retrospective cohort study

Characterisation of the vaginal microbiome in cervical intraepithelial neoplasia

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

HPV testing in the context of post-treatment follow up (test of cure)

Clinical performance of the novel full‐genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework

Agreement between L1 and E6/E7-based assays for detection of high-risk HPV in cervical, oropharyngeal and penile cancers

The challenges of defining sample adequacy in an era of HPV based cervical screening

The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis

Clinical performance of DNA and RNA based HPV tests for test of cure (TOC) post treatment for cervical intraepithelial neoplasia (CIN) - a retrospective study

Metaproteomic analysis from cervical biopsies and cytologies identifies proteinaceous biomarkers representing both human and microbial species

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework

The potential of biobanked liquid based cytology samples for cervical cancer screening using Raman spectroscopy

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years

Validation of EUROArray HPV test using the VALGENT framework

Suchergebnisse filtern